STOCK TITAN

Haemonetics Corp Mass (HAE) EPS by Year

HAE

Haemonetics Corp Mass earned $2.05 per diluted share in fiscal year 2026. This represents a decrease of 38.1% from the prior fiscal year. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to $2.07 per diluted share. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Haemonetics Corp Mass has filed alongside them.

FY2026 annual
EPS (Diluted) $2.05
YoY -38.1%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 27, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

HAE EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2610-KFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
EPS (Diluted)$2.07$2.05-38.1%$3.31$2.29+2.2%$2.24+166.7%$0.84-45.8%$1.55+4.7%$1.48+42.3%$1.04+22.4%$0.85+266.7%-$0.51+53.2%-$1.09-440.6%$0.32-52.2%$0.67-9.5%$0.74$1.30

TTM is the trailing twelve months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

HAE EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2710-QQ4'2610-QQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
EPS (Diluted)$0.72+2.9%-$0.41-135.0%$0.95+28.4%$0.81+22.7%$0.70-5.4%$1.17+192.5%$0.74+21.3%$0.66+37.5%$0.74+29.8%$0.40$0.61-4.7%$0.48+26.3%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Haemonetics Corp Mass financials

Frequently Asked Questions

What was Haemonetics Corp Mass's diluted earnings per share in fiscal year 2026?

Haemonetics Corp Mass earned $2.05 per diluted share in fiscal year 2026.

How fast is Haemonetics Corp Mass's diluted earnings per share growing?

Haemonetics Corp Mass (HAE) diluted earnings per share fell by 38.1% year over year, from $3.31 to $2.05 in fiscal year 2026.

What is Haemonetics Corp Mass's diluted earnings per share over the last twelve months?

Haemonetics Corp Mass (HAE) reported $2.07 per diluted share over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Haemonetics Corp Mass (HAE) diluted earnings per share went from $1.30 in fiscal year 2012 to $2.05 in fiscal year 2026.

Haemonetics Corp Mass (HAE) reported $0.72 in diluted earnings per share in Q1 2027. This represents an increase of 2.9% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Haemonetics Corp Mass (HAE) reported on that line in every period on record.